- Home
- XP vs ICLR Comparison
XP vs ICLR Comparison
Compare XP & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XP
- ICLR
- Stock Information
- Founded
- XP 2001
- ICLR 1990
- Country
- XP Cayman Islands
- ICLR Ireland
- Employees
- XP N/A
- ICLR N/A
- Industry
- XP Investment Bankers/Brokers/Service
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- XP Finance
- ICLR Health Care
- Exchange
- XP Nasdaq
- ICLR Nasdaq
- Market Cap
- XP 10.2B
- ICLR 11.4B
- IPO Year
- XP 2019
- ICLR 1998
- Fundamental
- Price
- XP $19.53
- ICLR $146.48
- Analyst Decision
- XP Strong Buy
- ICLR Buy
- Analyst Count
- XP 5
- ICLR 12
- Target Price
- XP $23.80
- ICLR $204.18
- AVG Volume (30 Days)
- XP 6.2M
- ICLR 1.1M
- Earning Date
- XP 08-12-2025
- ICLR 07-23-2025
- Dividend Yield
- XP 3.34%
- ICLR N/A
- EPS Growth
- XP 15.23
- ICLR 11.53
- EPS
- XP 1.51
- ICLR 9.19
- Revenue
- XP $2,886,046,386.00
- ICLR $8,192,621,999.00
- Revenue This Year
- XP $19.53
- ICLR N/A
- Revenue Next Year
- XP $12.59
- ICLR $2.10
- P/E Ratio
- XP $13.12
- ICLR $15.62
- Revenue Growth
- XP 9.27
- ICLR N/A
- 52 Week Low
- XP $10.82
- ICLR $125.10
- 52 Week High
- XP $20.64
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- XP 56.73
- ICLR 58.35
- Support Level
- XP $19.53
- ICLR $140.20
- Resistance Level
- XP $20.31
- ICLR $147.26
- Average True Range (ATR)
- XP 0.47
- ICLR 5.06
- MACD
- XP -0.15
- ICLR 1.39
- Stochastic Oscillator
- XP 28.85
- ICLR 85.25
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.